Request a Quote
NJ Biopharmaceuticals LLC and JEOL Ltd. Are Excited to Announce Their Collaboration to Bring Innovative Drug Discovery Platform Solutions Using JEOL’s 800 MHz NMR!
PRINCETON, N.J.--(BUSINESS WIRE)--NJ Bio is procuring an 800 MHz NMR spectrometer with a cryogenic probe from JEOL. As part of this collaboration, NJ Bio will contribute its expertise in antibody drug conjugates, oligonucleotide conjugates, and other chemistries to...
NJ Bio Awarded The Best Contract Research Provider (CRO) at the 8th Annual World ADC Awards, 2021
Princeton, NJ – NJ Biopharmaceutical (d/b/a NJ Bio), a global provider of outsourced integrated chemistry and biology services to clients in the pharmaceutical and biotechnology industries was awarded the Best Contract Research Provider Award, 2021 at the 8th Annual...
NJ Bio Welcomes Ilan Kaufthal as Senior Advisor and Pharmaceutical Executives, Ronald Gold, Steven Klosk, and Chetan Jain to its Board of Directors
NJ Biopharmaceuticals LLC (d/b/a NJ Bio), an expert provider of chemistry and biopharmaceutical services welcomed the appointments of Ilan Kaufthal as Senior Advisor, and Ronald Gold, Steven Klosk, and Chetan Jain to its Board of Directors. Ilan, Ron, Steve and Chetan...
NJ Bio Moves Headquarters to Princeton, New Jersey
NJ Bio, an expert in bioconjugation, nucleotide chemistry, custom synthesis, flow chemistry and process development, and application of BioNMR to drug discovery programs, is moving to new, state-of-the-art headquarters in Princeton, NJ.
NJ Bio has published a review article on Antibody-Oligonucleotide Conjugates
NJ Bio has published a review article on Antibody-Oligonucleotide Conjugates. Dugal-Tessier, J.; Thirumalairajan, S.; Jain, N. Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates. J. Clin. Med 2021,10, 838. https://doi.org/10.3390/jcm10040838...
NJ Bio Awarded Runner Up Prize as Best Contract Research Provider (CRO) at the 7th Annual World ADC Awards
North Brunswick, NJ and Bristol, PA — NJ Biopharmaceuticals LLC (d/b/a NJ Bio), a CRO providing integrated chemistry and biology services, was awarded Runner Up in the Best Contract Research Provider category at the 7th Annual World ADC Awards. The Best CRO Provider...
LakePharma and NJ Bio Form Strategic Alliance to Provide Streamlined Antibody-Drug Conjugate Services
SAN CARLOS, Calif. and NEW BRUNSWICK, N.J. — LakePharma, Inc., the leading US-based biologics CRDMO, and NJ Biopharmaceuticals LLC (d/b/a NJ Bio), a CRO providing integrated chemistry and biology services, today announce the formation of a strategic alliance to offer...
Workshop on ADC Chemistry at World ADC 2020 in London, UK
NJ Bio would like to share that Dr. Naresh Jain, NJ Bio’s President & CEO, and Dr. Julien Dugal-Tessier, NJ Bio’s Director of Innovative Chemistry and Innovation, will hold a Workshop at the 10th Annual World ADC London 2020. The workshop will be titled “The...
NJ Bio’s President & CEO, Dr. Naresh Jain, has received UAA-ICT’s Distinguished Alumnus Award
Dr. Naresh Jain, NJ Bio’s President & CEO, has been presented with this year’s UAA-ICT Distinguished Alumnus Award in the Research Category by the UDCT Alumni Association (UAA). This prestigious award, given out annually in five categories, was awarded to Dr. Jain...
Dr. Jagath R. Junutula and Dr. Zhihua Sui have joined NJ Bio’s Scientific Advisory Board
NJ Bio is pleased to announce that Dr. Jagath Reddy Junutula and Dr Zhihua Sui two well-known and esteemed industry experts in oncology drug discovery (including ADCs) and medicinal chemistry/drug discovery, respectively, have joined NJ Bio’s Scientific Advisory Board...